Apelin Gene Therapy Increases Autophagy Via Activation of Sirtuin 3 in Diabetic Heart
Journal Title: Diabetes Research – Open Journal - Year 2015, Vol 1, Issue 4
Abstract
Heart failure is the leading cause of death in diabetic patients. Recently we showed that apelin gene therapy attenuates heart failure following myocardial infarction. This study further explored the potential mechanisms by which apelin may reduce cardiac injury in Postmyocardial infarction (MI)) model of diabetes. Wild type and Sirt3 knockout (Sirt3 KO) mice were induced into diabetes by intra-peritoneal (i.p.) Streptozotocin (STZ). STZ mice were then subjected to MI followed by immediate intramyocardial injection with Adenovirus-apelin (Adapelin). Ad-apelin treatment resulted in over expression of apelin in the ischemic hearts of STZ mice. Apelin over expression led to a significant increase in Sirt3 expression. Apelin over expression significantly reduced gp91phox expression. This was accompanied by a significant reduction of reactive oxygen species formation. Ad-apelin treatment also dramatically reduced NF-κb-p65 expression in WT-STZ mice. Over expression of apelin further enhanced autophagy markers (LC3-II and beclin-1) expression in post-MI heart. Most intriguingly, knockout of Sirt3 in STZ mice abolished these beneficial effects of apelin treatment. In vitro, knockout of Sirt3 in EPCs significantly enhanced high glucose-induced ROS formation. Conversely, treatment of Sirt3 KO-EPCs with NADPH oxidase inhibitor led to two fold increase in LC3-II levels. Our studies demonstrate that apelin increases autophagy via up regulation of Sirt3 and suppression of ROS-NF-κb pathway in diabetic heart.
Authors and Affiliations
Jian-Xiong Chen
Keywords
Related Articles
- EP ID EP550115
- DOI 10.17140/DROJ-1-115
- Views 125
- Downloads 0
Rapid Improvement of Blood Glucose Level after Prosthetic Mandibular Advancement in a Patient with Diabetes Mellitus and Obstructive Sleep Apnea
Introduction: Obstructive Sleep Apnea Syndrome (OSAS) is often associated with impaired glucose metabolism. However, the effects of Prosthetic Mandibular Advancement (PMA) on blood glucose levels and insulin resistance r...
Behavioural Indicators as Risk of Diabetes Mellitus: A Community based Study in Manipur
Background: Diabetes Mellitus (DM) has become a major health issue all over the world. Lifestyle factors may affect the health of the patients with diabetes directly or indirectly. Family history of diabetes was given im...
Do we Need New Therapies for Diabetes?
Diabetes research and practice cluster (drug developers, payers, regulators and physicians) often (and especially in recent times) question the need of new therapies. Why would we need new therapies nowadays, when we hav...
A Multicenter Italian Survey on Diabetes Care Units Reveals a Somewhat Slow Attitude in Treatment Guideline Implementation: Are We Dealing With Therapeutic Inertia?
Aim: Current guidelines suggest pursuing optimal metabolic management ever since the onset of type 2 diabetes mellitus (T2DM). Nevertheless, over 50% Italian patients fail to meet expected metabolic targets. The aim of o...
Advances in Type 1 Diabetes Ocular Remote Tele-Health Screening
Background: Type 1 diabetes affects approximately 3 million Americans. Subjects are on average 14-years-old at time of diagnosis. It is a systemic, chronic condition that has retinal complications. Yearly ophthalmic cons...